Clinical value of new drugs in acute myeloid leukemia

Clinical value of new drugs in acute myeloid leukemia

Bibliographic Details
Main Author:	Gert Ossenkoppele
Format:	Article
Language:	English
Published:	Wiley 2019-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/HS9.0000000000000223

Similar Items

Acute myeloid leukemia
by: Gert Ossenkoppele
Published: (2018-06-01)

Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges?
by: Jannik Stemler, et al.
Published: (2022-07-01)

Leukemic stem cell frequency: a strong biomarker for clinical outcome in acute myeloid leukemia.
by: Monique Terwijn, et al.
Published: (2014-01-01)

Immunomodulatory Drugs in Acute Myeloid Leukemia Treatment
by: Antonio Piccolomo, et al.
Published: (2020-09-01)

Drug Repurposing for the Treatment of Acute Myeloid Leukemia
by: Vibeke Andresen, et al.
Published: (2017-11-01)

Recent drug approvals for acute myeloid leukemia
by: Catherine Lai, et al.
Published: (2019-09-01)

BCL-2 inhibitor and conventional chemotherapy combinations for acute myeloid leukemia: shifting from the unfit to the fit patient with AML
by: Ossenkoppele, G, et al.
Published: (2020)

Advances in the drug therapies of acute myeloid leukemia (except acute promyelocytic leukemia)
by: Lin M, et al.
Published: (2018-04-01)

Clonal architecture predicts clinical outcomes and drug sensitivity in acute myeloid leukemia
by: Brooks A. Benard, et al.
Published: (2021-12-01)

Can the New and Old Drugs Exert an Immunomodulatory Effect in Acute Myeloid Leukemia?
by: Francesco Tarantini, et al.
Published: (2021-08-01)

Clinical Implications of Inflammation in Acute Myeloid Leukemia
by: Christian Récher
Published: (2021-02-01)

Acute myeloid leukemia
by: Torsten Haferlach, (Coordinating Author)
Published: (2019-06-01)

New approaches in treatment of acute myeloid leukemia
by: Ebru Koca
Published: (2022-06-01)

NEW ADVANCES IN PEDIATRIC ACUTE MYELOID LEUKEMIA
by: Özlem Tüfekçi
Published: (2021-11-01)

Gemtuzumab ozogamicin and novel antibody-drug conjugates in clinical trials for acute myeloid leukemia
by: Bo Yu, et al.
Published: (2019-10-01)

Prognostic value of postinduction medullary myeloid recovery by flow cytometry in acute myeloid leukemia
by: Céline Row, et al.
Published: (2024-02-01)

Bayesian interim analysis for prospective randomized studies: reanalysis of the acute myeloid leukemia HOVON 132 clinical trial
by: Niek G. van der Maas, et al.
Published: (2024-03-01)

Prediction model for drug response of acute myeloid leukemia patients
by: Quang Thinh Trac, et al.
Published: (2023-03-01)

Drug Resistance Mechanisms of Acute Myeloid Leukemia Stem Cells
by: Jialan Niu, et al.
Published: (2022-07-01)

Progress in Development of Targeted Therapeutic Drugs for Acute Myeloid Leukemia
by: JI Xiaojun, et al.
Published: (2023-04-01)

PROGNOSTIC VALUE OF BRAIN AND ACUTE LEUKEMIA CYTOPLASMIC GENE EXPRESSION IN EGYPTIAN CHILDREN WITH ACUTE MYELOID LEUKEMIA
by: adel abd elhaleim hagag
Published: (2015-04-01)

Chronic myeloid leukemia versus acute myeloid leukemia in patients with retinoblastoma
by: Ann-Marie Leahey, et al.
Published: (2021-01-01)

Acute Myeloid Leukemia—Genetic Alterations and Their Clinical Prognosis
by: Francisco Alejandro Lagunas-Rangel, et al.
Published: (2016-07-01)

Clinical features of secondary acute myeloid leukemia in children
by: F. A. Makhacheva, et al.
Published: (2020-12-01)

New Therapeutic Strategies for Adult Acute Myeloid Leukemia
by: Hiroto Ishii, et al.
Published: (2022-06-01)

Hemophagocytosis in acute myeloid leukemia
by: Claudia Morales-Olvera, et al.
Published: (2024-01-01)

Acute Myeloid Leukemia: Is It T Time?
by: Meriem Ben Khoud, et al.
Published: (2021-05-01)

Bullous drug eruption with leukemic cell infiltrate in the setting of new-onset acute myeloid leukemia
by: Trisha Khanna, BS, et al.
Published: (2017-11-01)

Differential prognostic values of the three AKT isoforms in acute myeloid leukemia
by: Eulalie Corre, et al.
Published: (2024-03-01)

Evaluating the prognostic value of CD56 in pediatric acute myeloid leukemia
by: Tianqi Liang, et al.
Published: (2022-12-01)

Systematic review of health state utility values for acute myeloid leukemia
by: Forsythe A, et al.
Published: (2018-01-01)

Advances in Acute Myeloid Leukemia: Recently Approved Therapies and Drugs in Development
by: Michele Stanchina, et al.
Published: (2020-11-01)

TP-0903 is active in models of drug-resistant acute myeloid leukemia
by: Jae Yoon Jeon, et al.
Published: (2020-12-01)

Treatment results of pediatric acute myeloid leukemia with epigenetic drugs addition
by: V. S. Nemirovchenko, et al.
Published: (2020-07-01)

Correction Notice: Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges? Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies
Published: (2022-07-01)

Immunomodulatory Drugs Exert Anti-Leukemia Effects in Acute Myeloid Leukemia by Direct and Immunostimulatory Activities
by: Aude Le Roy, et al.
Published: (2018-05-01)

Clinical Significance of TARP Expression in Pediatric Acute Myeloid Leukemia
by: Barbara Depreter, et al.
Published: (2020-04-01)

Immunotherapies of acute myeloid leukemia: Rationale, clinical evidence and perspective
by: Yunyi Wu, et al.
Published: (2024-02-01)

Clinical Impact of Measurable Residual Disease in Acute Myeloid Leukemia
by: Tali Azenkot, et al.
Published: (2022-07-01)

The clinical impact of IKZF1 mutation in acute myeloid leukemia
by: Xiang Zhang, et al.
Published: (2023-03-01)